This inventor holds 1 USPTO granted patent. Top assignee: Innate Pharma, S.a.. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: Chantal Menut: Innovator in Phosphonate Derivatives
Introduction
Chantal Menut is a prominent inventor based in Montferrier sur Lez, France. She has made significant contributions to the field of pharmaceutical sciences, particularly through her innovative work on phosphonate derivatives.
Latest Patents
Chantal Menut holds a patent for "Phosphonates useful as modulators of T-γ-9-δ-2 activity." This invention involves novel phosphonate derivatives and their preparation methods. The patent also details their use as ligands that modulate T γ9δ2 lymphocyte activity, along with pharmaceutical compositions that incorporate these compounds. She has 1 patent to her name.
Career Highlights
Chantal Menut is currently associated with Innate Pharma, S.A., a company dedicated to developing innovative immunotherapies for cancer treatment. Her work at Innate Pharma has positioned her as a key player in the advancement of therapeutic solutions.
Collaborations
Throughout her career, Chantal has collaborated with notable colleagues, including Jean-Louis Montero and Ibrahim Zgani. These partnerships have fostered a collaborative environment that enhances research and development efforts.
Conclusion
Chantal Menut's contributions to the field of phosphonate derivatives exemplify her innovative spirit and dedication to advancing pharmaceutical sciences. Her work continues to impact the development of new therapeutic strategies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile